Aquestive Therapeutics Announces FDA Acceptance of Anaphylm™ NDA Resubmission and PDUFA Goal Date of March 16, 2027
Go back to Aquestive Therapeutics Announces FDA Acceptance of Anaphylm™ NDA Resubmission and PDUFA Goal Date of March 16, 2027| (NASDAQ: AQST) | Delayed: 4.08 +0.03 (0.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.05 | 52 Week High | $ | |||
| Open | $4.08 | 52 Week Low | $ | |||
| Day High | $4.19 | P/E | N/A | |||
| Day Low | $4.02 | EPS | $ | |||
| Volume | 1,571,350 | |||||



